Innate Pharma: Change at the top
Co-founder of immuno-oncology start-up Innate Pharma Hervé Brailly is making room on the chair of the executive board. His successor Mondher Majhoubi transfers from AstraZeneca, where he was Senior Vice President, Therapeutic Area Head-Oncology, Global Product and Portfolio Strategy.
Mahjoubi will take over as Chairman of Innate Pharmas Executive Board at the end of December. Brailly, in turn, is set to become Chairman of the Supervisory Board.
Mahjoubi is a medical oncologist trained at Institut Gustave Roussy in Paris. At AstraZeneca, he was instrumental in driving the oncology. Before AstraZeneca, he worked for pharma companies such as Aventis, Sanofi and Roche-Genentech.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium